Market Overview

Analysts See Allergan Bid Of Over $180, Possibility of 'Hostile' Bid


Bernstein analyst Aaron Gal reported that Valeant Pharmaceuticals International's (NYSE: VRX) offer for Allergan (NYSE: AGN) should be in the $190.00 per share range.

Gal reported that Valeant should offer $190.00 per share cash or an option of part of the deal in cash. The analyst added if Valeant is willing to take on higher debt, the company could get 25 percent of Allergan shareholders to take equity. Bernstein sees Valeant delaying a counter offer to May 28, in order to find additional financing.

The analyst remarked that a cash and stock deal is a “self-fulfilling prophecy” contingent on the deal being regarded as a gain for Valeant and an increase in the company's offer. Bernstein reported current trading suggests that investors are skeptical that a deal will close.

In a report on Monday, Citi analyst Liav Abraham commented that he sees Valeant “significantly” raising its bid, including the cash part of the offer. Citi sees an offer price of over $180.00 per share, with a good chance of the bid going hostile.

Shares of Valeant traded as high as $132.15, up 3.88 percent, on Tuesday and closed at $130.97, up 2.96 percent.

Shares of Allergan closed Tuesday at $161.90, up 1.38 percent.


Related Articles (AGN)

View Comments and Join the Discussion!

Posted-In: Aaron Gal Bernstein Citi Liav Abraham Pharma StocksAnalyst Color Financing Offerings

Latest Ratings

BIIBRBC CapitalMaintains277.0
RLICompass PointInitiates Coverage On90.0
CSCOWolfe ResearchDowngrades42.0
GILDRBC CapitalMaintains86.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at